Our work in Thailand

Our work in Thailand

WHO & Royal Thai Government: Partnering for a Healthier Thailand

The World Health Organization (WHO) is dedicated to improving the health and well-being of everyone in Thailand. Working hand-in-hand with the Royal Thai Government and a wide range of partners, the WHO's sixth Country Cooperation Strategy (CCS) for 2022-2026 outlines a collaborative approach to achieving this goal. 

 

A Collaborative Approach

The CCS represents a shared commitment to improving health in Thailand. Over 60 stakeholders, spanning government agencies, academia, and civil society, are actively collaborating to tackle key health challenges. The WHO serves as a facilitator, leveraging its expertise and influence to drive this broad partnership.

WHO Thailand’s work

WHO’s work in Thailand is based on the Country Cooperation Strategy (CCS) 2022 - 2026, it describes WHO’s medium-term strategic vision to guide the Organization’s work in Thailand. Most importantly, it describes six priority programmes on which the Ministry of Public Health in Thailand, its numerous partners, and the World Health Organization will work jointly over the next 5 years. These programmes address some of the critical public health issues facing Thailand in its unique context – an upper-middle-income country that has pioneered universal health coverage and that is committed to improving health through knowledge generation, evidenced-based policy, and social/political action. It works to improve systems needed to implement national health policies, strategies and plans, and to achieve national targets under the Sustainable Development Goals.

Key Focus Areas

The CCS outlines six strategic priorities, addressing crucial health challenges in Thailand:

  • Digital Health: Streamlining digital health platforms and health information systems for improved healthcare delivery.
  • Enhancing Leadership in Global Health (EnLIGHT) : Strengthening Thailand's role as a leader in global health initiatives.
  • Migrant Health: Improving healthcare services and access for migrant populations.
  • Noncommunicable Diseases: Addressing the burden of diseases like heart disease, cancer, and diabetes through prevention and control efforts.
  • Public Health Emergencies: Enhancing preparedness and response capabilities to effectively manage health emergencies.
  • Road Safety: Reducing road traffic accidents and injuries through targeted interventions.

Features activities

All →

Publications and information resources

All →
Mekong Malaria Elimination Programme epidemiology summary, volume 30, April-June 2025

The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's...

Eradicating cervical cancer in Thailand: A journey of hope and progress

Thailand has made significant progress in cervical cancer control and is on track to achieve the 90-70-90 targets by 2030, particularly through HPV vaccination...

Mekong Malaria Elimination Programme epidemiology summary, volume 29, January–March 2025

The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's...

Mekong Malaria Elimination Programme epidemiology summary, volume 28, October-December 2024

The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's...

Learning from pandemic responses: Informing a resilient and equitable health system recovery in Thailand

Learning from pandemic responses: Informing a resilient and equitable health system recovery in Thailand

Overview

As of 25 September 2022, Thailand reported 4.7 million COVID-19 cases, and 32,721 deaths;
equivalent to 65,329 cases and 456.8 deaths per million population (1). Thailand ranks 142nd and
137th globally in terms of cases and deaths per million population. COVID-19 vaccine rollout
began in May 2021; by September 2022, 79.6% of the Thai population were fully vaccinated and
44.7% had received booster doses (2).
Wilasang et al. (3) estimated excess deaths in 2021 at 14.3% (95%CI: 8.6–18.8%) higher than
the expected mortality projected from the last five years. Another study estimated excess deaths
between 2020 and 2021 at 24.9 per 100,000 population, compared with reported deaths of 15.3
per 100,000 population (4). This rate is considerably lower than the global all-age rate of 120.3.

WHO Team
Thailand
Number of pages
8